Stock market announcement archive

Correction: LIFE: Lifecare ASA Q2 2024

August 30, 2024
Reference is made to the Q2 2024 report published by Lifecare ASA (the “Company”) on 27 August 2024. In connection with the uplisting to Euronext Oslo Børs, the Company has conducted new assessments of its financial statements and, in collaboration with its auditor, concluded to recognize the warrants issued in connection with the previously announced […]
Read more

LIFE: Lifecare ASA Q2 2024

August 27, 2024
Bergen, Norway, 27 August 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q2 financial report and operational update. In the second quarter Lifecare continued to build positive momentum towards automatic production by delivering milestones on a continuous basis over a long […]
Read more

Lifecare semi-annual report – strategic measures lead to strong increase in external revenue and increased operational capacity

August 25, 2022
Bergen, 25 August 2022. Today, Lifecare present strong financial results following the first half-yearwith operational activities in two German subsidiaries as part of the LifecareGroup. The external revenue in 1H 2022 reached a total of 8,7MNOK, representingan increase of +8,7MNOK from 1H 2021 (from 0,0 MNOK) and +7,1MNOK from EY 2021(from 1,6MNOK). A steep increase […]
Read more

LIFE: Interim report first half 2021

August 5, 2021
Bergen, Norway 05.08.21Please find attached Lifecare AS' unaudited Interim Report for first half 2021.The report is also available on https://www.lifecare.attme.dev Further informationJoacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.attme.dev, +47 40 05 90 40This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act. This stock exchange announcement waspublished by Kine Hereid, […]
Read more